Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Fentanyl for Vaso-occlusive Crisis in Sickle Cell Disease
NCT01482091Phase 4Completed
- Sponsor
- Montefiore Medical Center
- Start
- Dec 2011
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fentanyl in sickle cell disease (SCD), sponsored by Montefiore Medical Center. Started Dec 2011; status: completed.
02
Drugs
fentanyl
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01482091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01482091.